Publications by authors named "J P Karwowski"
Article Synopsis
- Atrial fibrillation (AF) is common among patients receiving cardiac resynchronization therapy (CRT) and affects the effectiveness of the treatment by reducing biventricular pacing (BiVp) beats.
- This study aimed to compare the effectiveness of rhythm control (using electrical cardioversion) versus rate control (using atrioventricular node ablation) strategies in CRT recipients suffering from persistent AF.
- Results showed that while both strategies improved BiVp percentage similarly, only patients who restored sinus rhythm experienced a significant increase in left ventricular ejection fraction (LVEF), indicating the importance of maintaining normal heart rhythm in these patients.
Navigation lies at the core of social robotics, enabling robots to navigate and interact seamlessly in human environments. The primary focus of human-aware robot navigation is minimizing discomfort among surrounding humans. Our review explores user studies, examining factors that cause human discomfort, to perform the grounding of social robot navigation requirements and to form a taxonomy of elementary necessities that should be implemented by comprehensive algorithms.
View Article and Find Full Text PDFBackground: Knowledge of thrombosis (T) risk predictors and transesophageal echocardiography (TEE) are important tools in appropriate qualification of patients for safe electrical cardioversion.
Aims: We aimed to investigate predictors of T and spontaneous echocardiographic contrast (SEC) with sludge in the left atrium (LA) and appendage (LAA) in atrial fibrillation (AF) patients on oral anticoagulation.
Methods: The study included 300 patients with AF lasting >48 hours.
This study aimed to assess the safety of electric cardioversion in the absence of anesthetists assistance. We also evaluated the efficacy and safety of this procedure in older adults (≥80 years) compared to younger populations. We retrospectively analyzed the data of patients who underwent electric cardioversion at our cardiology department.
View Article and Find Full Text PDFIntroduction: Antazoline is a frequently used antiarrhythmic drug (AAD); however, to date, no randomized controlled trial has evaluated its efficacy and safety for cardioversion of recent‑onset atrial fibrillation (AF) in comparison with other approved AADs.
Objectives: This study aimed to compare clinical efficacy and safety of antazoline and propafenone for a rapid conversion of nonvalvular paroxysmal AF to sinus rhythm in patients without heart failure.
Patients And Methods: This was a single‑center, randomized, double‑blind study.